QSS
BIO icon

Quantitative Systematic Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantitative Systematic Strategies’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,812
Closed -$1.17M – 57
2021
Q2 		$1.17M Sell
1,812
-2,786
-61% -$1.7M 0.41% 46
2021
Q1 		$2.63M Buy
4,598
+1,327
+41% +$786K 0.41% 49
2020
Q4 		$1.91M Buy
3,271
+764
+30% +$435K 0.27% 109
2020
Q3 		$1.29M Buy
2,507
+168
+7% +$85.1K 0.23% 136
2020
Q2 		$1.06M Buy
2,339
+1,574
+206% +$695K 0.21% 157
2020
Q1 		$268K Buy
+765
New +$281K 0.22% 167
2019
Q4 		– Sell
-1,362
Closed -$453K – 547
2019
Q3 		$453K Sell
1,362
-1,731
-56% -$565K 0.1% 252
2019
Q2 		$967K Buy
3,093
+2,149
+228% +$643K 0.18% 161
2019
Q1 		$289K Sell
944
-2,369
-72% -$639K 0.07% 258
2018
Q4 		$769K Buy
3,313
+932
+39% +$250K 0.17% 188
2018
Q3 		$745K Sell
2,381
-2,049
-46% -$636K 0.14% 235
2018
Q2 		$1.28M Buy
4,430
+82
+2% +$22.6K 0.23% 137
2018
Q1 		$1.09M Sell
4,348
-239
-5% -$60.9K 0.23% 144
2017
Q4 		$1.09M Buy
4,587
+2,568
+127% +$622K 0.28% 117
2017
Q3 		$449K Sell
2,019
-792
-28% -$178K 0.12% 255
2017
Q2 		$630K Sell
2,811
-8,226
-75% -$1.79M 0.16% 200
2017
Q1 		$2.2M Buy
11,037
+9,817
+805% +$1.89M 0.62% 41
2016
Q4 		$223K Sell
1,220
-5,684
-82% -$969K 0.09% 266
2016
Q3 		$1.12M Buy
+6,904
New +$1.05M 0.41% 88
2016
Q1 		– Sell
-2,169
Closed -$303K – 448
2015
Q4 		$303K Buy
+2,169
New +$301K 0.08% 572

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantitative Systematic Strategies's BIO Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 1,812 shares — an estimated $1.17M sold.

Quantitative Systematic Strategies first reported a position in BIO in Q4 2015 and held it in 20 quarters. The position peaked at $2.63M in Q1 2021. 507 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,812 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $1.17M.
  • Quantitative Systematic Strategies first reported a position in Bio-Rad Laboratories Class A in Q4 2015 and held it in 20 quarters.
  • Quantitative Systematic Strategies's Bio-Rad Laboratories Class A position peaked at $2.63M in Q1 2021.
  • 507 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.